Negar Pedram

Targeting lncRNA PVT1/miR‐145‐5p/ABCC‐1 Pathway Enhances Paclitaxel Sensitivity and Suppresses Melanoma Progression

Background As a highly aggressive type of skin cancer, melanoma cells show significant resistance against a variety of chemotherapeutics, such as paclitaxel, which limits the efficacy of the treatment. Studies have highlighted the potential role of noncoding RNA dysregulation in melanoma, affecting tumor progression an...